Steven Stice, D.W. Brooks Distinguished Professor, Georgia Research Alliance Eminent Scholar Chair in Animal Reproductive Physiology, and director of the Regenerative Bioscience Center, has led industry and academic research teams in the area of pluripotent stem cells for over 25 years. Stice has co-founded five companies and been issued 69 domestic and international patents. His first company, Advanced Cell Technologies, was the first to secure a U.S. patent on animal cloning and therapeutic cloning from adult animal cells. His current company, ArunA Bio, focuses on drug treatments for neurodegenerative and neurological disease and is beginning its first clinical trials in 2023. ArunA Bio was the first company to commercialize a product derived from human pluripotent stem cells and cell development, which was used to facilitate approval of Pfizer’s current cognitive-enhancing pharmaceuticals. Stice continually plays a vital role in promoting entrepreneurship in the Athens and Georgia bioscience communities.